简化的基于规则的工具,便于在心脏肿瘤学中应用最新的管理建议。

IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Sherry-Ann Brown, Abdulaziz Hamid, Erin Pederson, Allen Hanna Bs, Ragasnehith Maddula, Rachel Goodman, Morgan Lamberg, Pedro Caraballo, Peter Noseworthy, Opeoluwa Lukan, Gift Echefu, Generika Berman, Indrajit Choudhuri
{"title":"简化的基于规则的工具,便于在心脏肿瘤学中应用最新的管理建议。","authors":"Sherry-Ann Brown,&nbsp;Abdulaziz Hamid,&nbsp;Erin Pederson,&nbsp;Allen Hanna Bs,&nbsp;Ragasnehith Maddula,&nbsp;Rachel Goodman,&nbsp;Morgan Lamberg,&nbsp;Pedro Caraballo,&nbsp;Peter Noseworthy,&nbsp;Opeoluwa Lukan,&nbsp;Gift Echefu,&nbsp;Generika Berman,&nbsp;Indrajit Choudhuri","doi":"10.1186/s40959-023-00179-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Millions of cancer survivors are at risk of cardiovascular diseases, a leading cause of morbidity and mortality. Tools to potentially facilitate implementation of cardiology guidelines, consensus recommendations, and scientific statements to prevent atherosclerotic cardiovascular disease (ASCVD) and other cardiovascular diseases are limited. Thus, inadequate utilization of cardiovascular medications and imaging is widespread, including significantly lower rates of statin use among cancer survivors for whom statin therapy is indicated.</p><p><strong>Methods: </strong>In this methodological study, we leveraged published guidelines documents to create a rules-based tool to include guidelines, expert consensus, and medical society scientific statements relevant to point of care cardiovascular disease prevention in the cardiovascular care of cancer survivors. Any overlap, redundancy, or ambiguous recommendations were identified and eliminated across all converted sources of knowledge. The integrity of the tool was assessed with use case examples and review of subsequent care suggestions.</p><p><strong>Results: </strong>An initial selection of 10 guidelines, expert consensus, and medical society scientific statements was made for this study. Then 7 were kept owing to overlap and revisions in society recommendations over recent years. Extensive formulae were employed to translate the recommendations of 7 selected guidelines into rules and proposed action measures. Patient suitability and care suggestions were assessed for several use case examples.</p><p><strong>Conclusion: </strong>A simple rules-based application was designed to provide a potential format to deliver critical cardiovascular disease best-practice prevention recommendations at the point of care for cancer survivors. A version of this tool may potentially facilitate implementing these guidelines across clinics, payers, and health systems for preventing cardiovascular diseases in cancer survivors.</p><p><strong>Trial registration: </strong>ClinicalTrials.Gov Identifier: NCT05377320.</p>","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605976/pdf/","citationCount":"0","resultStr":"{\"title\":\"Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.\",\"authors\":\"Sherry-Ann Brown,&nbsp;Abdulaziz Hamid,&nbsp;Erin Pederson,&nbsp;Allen Hanna Bs,&nbsp;Ragasnehith Maddula,&nbsp;Rachel Goodman,&nbsp;Morgan Lamberg,&nbsp;Pedro Caraballo,&nbsp;Peter Noseworthy,&nbsp;Opeoluwa Lukan,&nbsp;Gift Echefu,&nbsp;Generika Berman,&nbsp;Indrajit Choudhuri\",\"doi\":\"10.1186/s40959-023-00179-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Millions of cancer survivors are at risk of cardiovascular diseases, a leading cause of morbidity and mortality. Tools to potentially facilitate implementation of cardiology guidelines, consensus recommendations, and scientific statements to prevent atherosclerotic cardiovascular disease (ASCVD) and other cardiovascular diseases are limited. Thus, inadequate utilization of cardiovascular medications and imaging is widespread, including significantly lower rates of statin use among cancer survivors for whom statin therapy is indicated.</p><p><strong>Methods: </strong>In this methodological study, we leveraged published guidelines documents to create a rules-based tool to include guidelines, expert consensus, and medical society scientific statements relevant to point of care cardiovascular disease prevention in the cardiovascular care of cancer survivors. Any overlap, redundancy, or ambiguous recommendations were identified and eliminated across all converted sources of knowledge. The integrity of the tool was assessed with use case examples and review of subsequent care suggestions.</p><p><strong>Results: </strong>An initial selection of 10 guidelines, expert consensus, and medical society scientific statements was made for this study. Then 7 were kept owing to overlap and revisions in society recommendations over recent years. Extensive formulae were employed to translate the recommendations of 7 selected guidelines into rules and proposed action measures. Patient suitability and care suggestions were assessed for several use case examples.</p><p><strong>Conclusion: </strong>A simple rules-based application was designed to provide a potential format to deliver critical cardiovascular disease best-practice prevention recommendations at the point of care for cancer survivors. A version of this tool may potentially facilitate implementing these guidelines across clinics, payers, and health systems for preventing cardiovascular diseases in cancer survivors.</p><p><strong>Trial registration: </strong>ClinicalTrials.Gov Identifier: NCT05377320.</p>\",\"PeriodicalId\":9804,\"journal\":{\"name\":\"Cardio-oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2023-10-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605976/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardio-oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40959-023-00179-w\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardio-oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40959-023-00179-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:数以百万计的癌症幸存者有患心血管疾病的风险,心血管疾病是发病率和死亡率的主要原因。潜在促进实施心脏病学指南、共识建议和科学声明以预防动脉粥样硬化性心血管疾病(ASCVD)和其他心血管疾病的工具是有限的。因此,心血管药物和成像的不充分利用是普遍存在的,包括癌症幸存者中他汀类药物的使用率明显较低,他汀类药物治疗是指他汀类药物。方法:在这项方法学研究中,我们利用已发表的指南文件创建了一个基于规则的工具,其中包括与癌症幸存者心血管护理中的护理点心血管疾病预防相关的指南、专家共识和医学会科学声明。在所有转换的知识来源中,发现并消除了任何重叠、冗余或模棱两可的建议。该工具的完整性通过用例示例和后续护理建议的审查进行了评估。结果:本研究初步选择了10项指南、专家共识和医学会科学声明。然后,由于近年来社会建议的重叠和修订,保留了7项。采用了广泛的公式,将7项选定准则的建议转化为规则和拟议的行动措施。对几个使用案例的患者适用性和护理建议进行了评估。结论:设计了一个简单的基于规则的应用程序,以提供一种潜在的形式,在癌症幸存者的护理点提供关键的心血管疾病最佳实践预防建议。该工具的一个版本可能有助于在诊所、付款人和卫生系统中实施这些指南,以预防癌症幸存者的心血管疾病。试验注册:临床试验。Gov标识符:NCT05377320。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.

Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.

Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.

Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology.

Background: Millions of cancer survivors are at risk of cardiovascular diseases, a leading cause of morbidity and mortality. Tools to potentially facilitate implementation of cardiology guidelines, consensus recommendations, and scientific statements to prevent atherosclerotic cardiovascular disease (ASCVD) and other cardiovascular diseases are limited. Thus, inadequate utilization of cardiovascular medications and imaging is widespread, including significantly lower rates of statin use among cancer survivors for whom statin therapy is indicated.

Methods: In this methodological study, we leveraged published guidelines documents to create a rules-based tool to include guidelines, expert consensus, and medical society scientific statements relevant to point of care cardiovascular disease prevention in the cardiovascular care of cancer survivors. Any overlap, redundancy, or ambiguous recommendations were identified and eliminated across all converted sources of knowledge. The integrity of the tool was assessed with use case examples and review of subsequent care suggestions.

Results: An initial selection of 10 guidelines, expert consensus, and medical society scientific statements was made for this study. Then 7 were kept owing to overlap and revisions in society recommendations over recent years. Extensive formulae were employed to translate the recommendations of 7 selected guidelines into rules and proposed action measures. Patient suitability and care suggestions were assessed for several use case examples.

Conclusion: A simple rules-based application was designed to provide a potential format to deliver critical cardiovascular disease best-practice prevention recommendations at the point of care for cancer survivors. A version of this tool may potentially facilitate implementing these guidelines across clinics, payers, and health systems for preventing cardiovascular diseases in cancer survivors.

Trial registration: ClinicalTrials.Gov Identifier: NCT05377320.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardio-oncology
Cardio-oncology Medicine-Cardiology and Cardiovascular Medicine
CiteScore
5.00
自引率
3.00%
发文量
17
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信